If you believe your money should support your values while you save it, you may want to explore the idea of ethical, or socially responsible, banking. Ethical banking is the practice of choosing ...

We recommend Chase, Chime, Bank of America, Capital One, and Wells Fargo as some of the best mobile banking apps today. Based on our research of many popular finance apps from top institutions, we ...

It’s possible to make $100s by opening a new bank account, but sorting through the best offers can be tricky. There’s no shortage of enticing opportunities for banking clients right now. We’re happy ...

memorable logo without breaking the bank. By leveraging cutting-edge technology and vast libraries of design elements, these tools enable users to create custom logos that perfectly capture their ...

Kat Aoki is a personal finance writer helping consumers make better decisions with their home loans, credit cards, banking products and more. Editorial Note: We earn a commission from partner ...

The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...

Meghan Markle recently unveiled her rebranded lifestyle brand, As Ever, and its new logo is packed with subtle nods to her family and personal history. The design features a palm tree encased by ...

IN8bio’s are centered on populating the expansion cohort for the INB-100 trial. The scientific team has met with the FDA in a Type B meeting to help guide the design of the registrational path ...

‘We’re working to get things back to normal as quickly as we can.’ The bank later updated to say that the problem had been resolved, though not before having to respond to dozens of unhappy user ...

The data, previously announced, reinforce INB-100’s potential to significantly reduce post-transplant relapse in high-risk acute myeloid leukemia (AML) patients, positioning this gamma-delta T cell ...

(RTTNews) - IN8bio, Inc. (INAB), a clinical-stage biopharmaceutical company, Friday announced promising results from its Phase 1 trials of INB-100, an allogeneic gamma-delta T cell therapy for ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, TCT, Meetings in Hawaii. The data, previously announced ...